p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cells.

Autor: Hassin O; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., Sernik M; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., Seligman A; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., Vogel FCE; Division of Tumor Metabolism and Microenvironment, German Cancer Research Center, Heidelberg 69120, Germany., Wellenstein MD; Division of Tumour Biology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam 1066CX, The Netherlands., Smollich J; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., Halperin C; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel., Pirona AC; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., Toledano LN; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., Caballero CD; Division of Tumor Metabolism and Microenvironment, German Cancer Research Center, Heidelberg 69120, Germany., Schlicker L; Division of Tumor Metabolism and Microenvironment, German Cancer Research Center, Heidelberg 69120, Germany., Salame TM; Mass Cytometry Unit, Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot 7610001, Israel., Sarusi Portuguez A; The Mantoux Bioinformatics Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot 7610001, Israel., Aylon Y; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., Scherz-Shouval R; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel., Geiger T; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., de Visser KE; Division of Tumour Biology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam 1066CX, The Netherlands., Schulze A; Division of Tumor Metabolism and Microenvironment, German Cancer Research Center, Heidelberg 69120, Germany., Oren M; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Dec 26; Vol. 120 (52), pp. e2311460120. Date of Electronic Publication: 2023 Dec 21.